CON · Concentra Group Holdings Parent, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $569.55M | - | $572.80M | $550.78M | $467.60M | - | $473.96M | $467.08M | - | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $55.28M | - | $52.88M | $52.93M | $36.91M | - | $37.09M | $36.83M | - | - |
| Total Operating Expenses | $474.01M | - | $478.33M | $461.26M | $392.38M | - | $403.40M | $385.12M | - | - |
| D&A | $19.65M | - | $19.91M | $19.00M | $18.48M | - | $15.21M | $18.28M | - | - |
| Operating Income | $95.61M | - | $94.47M | $89.54M | $75.50M | - | $80.95M | $83.94M | - | - |
| Interest Expense | $26.00M | - | - | - | $111.0K | - | - | - | - | - |
| Income Tax | $17.32M | - | $15.97M | $15.15M | $15.14M | - | $16.41M | $16.59M | - | - |
| Net Income | $50.49M | - | $48.26M | $44.56M | $38.91M | - | $44.34M | $51.74M | - | - |
| EPS - Basic | $0.39 | - | $0.38 | $0.35 | $0.47 | - | $0.37 | $0.51 | - | - |
| EPS - Diluted | $0.39 | - | $0.38 | $0.35 | $0.47 | - | $0.51 | $0.50 | - | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $61.70M | $79.90M | $49.94M | $73.87M | $52.11M | $183.25M | $136.82M | $50.67M | - | - |
| Accounts Receivable | $296.51M | $257.90M | $278.97M | $271.75M | $258.13M | $217.72M | $232.20M | $216.19M | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $31.74M | $21.00M | $32.79M | $38.88M | $35.19M | $19.75M | - | - | $20.41M | - |
| Current Assets | $404.21M | $383.10M | $375.44M | $395.17M | $351.59M | $437.21M | $409.96M | $294.42M | - | - |
| Total Assets | $2.89B | $2.86B | $2.84B | $2.84B | $2.37B | $2.52B | $2.48B | $2.33B | - | $2.30B |
| Current Liabilities | $320.88M | $337.25M | $312.65M | $335.07M | $320.39M | $307.19M | $269.52M | $274.63M | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $2.44B | $2.44B | $2.43B | $2.47B | $2.40B | $2.22B | $2.18B | $1.09B | - | - |
| Stockholders' Equity | $424.71M | $393.28M | $385.49M | $342.64M | $307.12M | $275.67M | $277.78M | $1.25B | - | $979.34M |
| Retained Earnings | $186.84M | $146.45M | $120.08M | $79.83M | $44.45M | $13.55M | $0 | $685.29M | - | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $21.02M | - | - | - | $44.62M | - | - | - | - | - |
| Investing Cash Flow | ($14.85M) | - | - | - | ($22.35M) | - | - | - | - | - |
| Financing Cash Flow | ($24.37M) | - | - | - | ($4.09M) | - | - | - | - | - |
| CapEx | $11.09M | - | - | - | $17.23M | - | - | - | - | - |
| Free Cash Flow | $9.93M | - | - | - | $27.39M | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q4 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 16.8% | - | 16.5% | 16.3% | 16.1% | - | 17.1% | 18.0% | - | - |
| EBITDA margin | 20.2% | - | 20.0% | 19.7% | 20.1% | - | 20.3% | 21.9% | - | - |
| Net margin | 8.9% | - | 8.4% | 8.1% | 8.3% | - | 9.4% | 11.1% | - | - |
| Free cash flow margin | 1.7% | - | - | - | 5.9% | - | - | - | - | - |
| FCF / Net income | 0.20 | - | - | - | 0.70 | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 9.7% | - | 9.2% | 9.6% | 7.9% | - | 7.8% | 7.9% | - | - |
| Effective tax rate | 25.5% | - | 24.9% | 25.4% | 28.0% | - | 27.0% | 24.3% | - | - |
| Return on assets | 1.7% | - | 1.7% | 1.6% | 1.6% | - | 1.8% | 2.2% | - | - |
| Return on equity | 11.9% | - | 12.5% | 13.0% | 12.7% | - | 16.0% | 4.1% | - | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.26 | 1.14 | 1.20 | 1.18 | 1.10 | 1.42 | 1.52 | 1.07 | - | - |
| Quick ratio | 1.26 | 1.14 | 1.20 | 1.18 | 1.10 | 1.42 | 1.52 | 1.07 | - | - |
| Cash ratio | 0.19 | 0.24 | 0.16 | 0.22 | 0.16 | 0.60 | 0.51 | 0.18 | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 3.7x | - | - | - | 680.2x | - | - | - | - | - |
| Equity multiplier | 6.80 | 7.27 | 7.38 | 8.29 | 7.70 | 9.15 | 8.93 | 1.87 | - | 2.35 |
| Liabilities / Assets | 0.84 | 0.85 | 0.86 | 0.87 | 1.01 | 0.88 | 0.88 | 0.47 | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.20 | - | 0.20 | 0.19 | 0.20 | - | 0.19 | 0.20 | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 190d | - | 178d | 180d | 201d | - | 179d | 169d | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 55.0x | - | 55.1x | 58.8x | 46.2x | - | 43.8x | - | - | - |
| P / B | 6.5x | - | 7.0x | 7.7x | 7.4x | - | 9.7x | - | - | - |
| P / S | 4.8x | - | 4.7x | 4.8x | 4.8x | - | 5.7x | - | - | - |
| EV / EBITDA | 23.4x | - | 23.0x | 23.6x | 23.5x | - | 26.7x | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 21.8% | - | 20.9% | 17.9% | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 26.6% | - | 16.7% | 6.7% | - | - | - | - | - | - |
| Net income growth (YoY) | 29.8% | - | 8.8% | -13.9% | - | - | - | - | - | - |
| EPS growth (YoY) | -17.0% | - | -25.5% | -30.0% | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | -63.7% | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 38.3% | 42.7% | 38.8% | -72.5% | - | - | - | - | - | 18.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$4.33B totalReportable Segment$2.16B · 50.0%
Occupational Health Center$2.01B · 46.4%
Onsite Health Clinics$110.24M · 2.5%
Other Businesses$47.52M · 1.1%
Product / service
$2.01B totalOccupational Health Center Workers Compensation$1.31B · 65.1%
Occupational Health Center Employer Services$659.54M · 32.9%
Occupational Health Center Consumer Health$31.30M · 1.6%
Occupational Health Center Other$8.60M · 0.4%
Peer comparison
Same SIC group: Services-Specialty Outpatient Facilities, NEC
Comparing Concentra Group Holdings Parent against the 5 most active filers in the same SIC group.
Dividends
$0.25/share trailing 12 months · +33.3% YoY
| Ex-date | Per share |
|---|---|
| May 19, 2026 | $0.0630 |
| Mar 12, 2026 | $0.0630 |
| Dec 2, 2025 | $0.0630 |
| Aug 21, 2025 | $0.0630 |
| May 20, 2025 | $0.0630 |
| Mar 18, 2025 | $0.0630 |
| Nov 13, 2024 | $0.0630 |